Back to top
more

Shockwave Medical Inc. (SWAV)

(Delayed Data from NSDQ)

$43.43 USD

43.43
437,633

+2.29 (5.57%)

Updated May 3, 2019 04:00 PM ET

After-Market: $43.32 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Shockwave Medical (SWAV) Gains 0.6% Post Q3 Earnings Beat

Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and expansion in gross margin.

Shockwave Medical (SWAV) Q3 Earnings and Revenues Surpass Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 171.43% and 5.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Shockwave Medical (SWAV) Report Negative Earnings Next Week? What You Should Know

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ShockWave Medical (SWAV) Sees Hammer Chart Pattern: Time to Buy?

ShockWave Medical (SWAV) has been struggling lately, but the selling pressure may be coming to an end soon.

Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?

Smart Beta ETF report for FNY

ShockWave Medical (SWAV) Q2 Earnings, Revenues Top Estimates

ShockWave Medical's (SWAV) robust performance across product lines and geographies drive its Q2 sales.

Company News for Aug 10, 2021

Companies In The News Are: BALY, CRNC, SWAV, VTRS

Shockwave Medical (SWAV) Reports Q2 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 97.56% and 28.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Why ShockWave Medical (SWAV) Might Surprise This Earnings Season

ShockWave Medical (SWAV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Shockwave Medical (SWAV) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Shockwave Medical (SWAV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -61.90% and 1.44%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Shockwave Medical (SWAV) Reports Q4 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.20% and 11.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Shockwave Medical (SWAV) Report Negative Earnings Next Week? What You Should Know

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shockwave Medical (SWAV) Reports Q3 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 30.91% and 34.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Shockwave Medical (SWAV) to Report a Decline in Earnings: What to Look Out for

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shockwave Medical (SWAV) Reports Q2 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 15.15% and 6.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Shockwave Medical (SWAV) Q2 Earnings Expected to Decline

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Shockwave Medical (SWAV) Reports Q1 Loss, Tops Revenue Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -22.92% and 20.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Shockwave Medical (SWAV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings?

DENTSPLY SIRONA (XRAY) Q3 earnings to reflect better-than-expected performance at Technology & Equipment and growth in emerging markets.

What's in the Cards for Cardinal Health (CAH) in Q1 Earnings?

Cardinal Health (CAH) Q1 earnings are likely to reflect better-than-expected performance at Pharmaceutical and Medical segments.

AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store?

AmerisourceBergen's (ABC) Q4 earnings are likely to reflect the better-than-expected performance at Pharmaceutical Distribution and higher revenues.

DexCom (DXCM) to Report Q3 Earnings: What's in the Offing?

DexCom's (DXCM) Q3 earnings is likely to reflect top-line growth and rising global awareness of the company's real-time CGM.